Determinants of VIA (visual inspection of the cervix after acetic acid application) positivity in cervical cancer screening of women in a peri-urban area in Andhra Pradesh, India

  • Haripriya Vedantham
  • , Michelle I. Silver
  • , B. Kalpana
  • , C. Rekha
  • , B. P. Karuna
  • , K. Vidyadhari
  • , S. Mrudula
  • , Brigitte M. Ronnett
  • , K. Vijayaraghavan
  • , Gayatri Ramakrishna
  • , Pavani Sowjanya
  • , Shantha Laxmi
  • , Keerti V. Shah
  • , Patti E. Gravitt

Research output: Contribution to journalArticlepeer-review

57 Scopus citations

Abstract

Objectives: Visual inspection of the cervix after acetic acid application (VIA) is widely recommended as the method of choice in cervical cancer screening programs in resource-limited settings because of its simplicity and ability to link with immediate treatment. In testing the effectiveness of VIA, human papillomavirus DNA testing, and Pap cytology in a population-based study in a peri-urban area in Andhra Pradesh, India, we found the sensitivity of VIA for detection of cervical intraepithelial neoplasia grade 2 and worse (CIN2+) to be 26.3%, much lower than the 60% to 90% reported in the literature. We therefore investigated the determinants of VIA positivity in our study population. Methods: We evaluated VIA positivity by demographics and reproductive history, results of clinical examination, and results from the other screening methods. Results: Of the 19 women diagnosed with CIN2+, only 5 were positive by VIA (positive predictive value, 3.1%). In multivariate analysis, VIA positivity (12.74%) was associated with older age, positive Pap smear, visually apparent cervical inflammation, and interobserver variation. Cervical inflammation of unknown cause was present in 21.62% of women. In disease-negative women, cervical inflammation was associated with an increase in VIA positivity from 6.1% to 15.5% (P < 0.001). Among the six gynecologists who performed VIA, the positivity rate varied from 4% to 31%. Conclusions: The interpretation of VIA is subjective and its performance cannot be readily evaluated against objective standards. Impact: VIA is not a robust screening test and we caution against its use as the primary screening test in resource-limited regions.

Original languageEnglish
Pages (from-to)1373-1380
Number of pages8
JournalCancer Epidemiology Biomarkers and Prevention
Volume19
Issue number5
DOIs
StatePublished - May 2010

Fingerprint

Dive into the research topics of 'Determinants of VIA (visual inspection of the cervix after acetic acid application) positivity in cervical cancer screening of women in a peri-urban area in Andhra Pradesh, India'. Together they form a unique fingerprint.

Cite this